OnKure
Latest round
- Series C
Last raised
- Mar 2023
Total raised
- $88M
Investors
- 9
About OnKure
OnKure, Inc. is a biopharmaceutical company dedicated to the discovery and development of precision medicines targeting cancer.OnKure, Inc. specializes in developing targeted cancer treatments. The company was co-founded by Anthony Piscopio and Xuedong Liu, with Anthony Piscopio currently serving as CEO.OnKure Therapeutics specializes in the discovery and development of precision medicines targeted at cancer treatment. Their core product offerings focus on tumor-agnostic oncology therapies that can be effective across various types of tumors. The company is advancing next-generation therapies that address significant unmet medical needs in the cancer treatment landscape.OnKure Therapeutics generates revenue through strategic partnerships and collaborations within the biopharmaceutical industry, engaging in B2B transactions with healthcare institutions and pharmaceutical partners. Revenue streams involve milestone payments from drug development phases and royalties from successful commercialized therapies, in line with industry standards for proprietary oncology medications.On March 24, 2023, OnKure, Inc. The company is also planning to expand its market presence in North America and Europe, targeting new healthcare institutions by the end of 2024.
Who invested in OnKure
9 investors across 3 rounds
See all investors in OnKure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about OnKure
Who invested in OnKure?
OnKure has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OnKure raised?
OnKure has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did OnKure last raise money?
OnKure's most recent round on record is a Series C, in Mar 2023.
What does OnKure do?
OnKure is a biotechnology company.
Where is OnKure headquartered?
OnKure is headquartered in Boulder, US.
Which VCs invest in companies like OnKure?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at OnKure's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like OnKure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.